Jose T. Ortiz‐Pérez

Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies

Xavier Bosch, Montserrat Rovira, Marta Sitges et al. · Journal of the American College of Cardiology · 2013 · 627 citations

Medicine, Cardiology, Pharmacology +11

Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS

Carlos Ferrando, Fernando Suárez-Sipmann, Ricard Mellado Artigas et al. · Intensive Care Medicine · 2020 · 478 citations · Full text

Health Professions, Infectious Diseases, Respiratory Therapy +17

Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study

Edwin Wu, Jose T. Ortiz‐Pérez, Paula Tejedor et al. · Heart · 2007 · 445 citations

Medicine, Cardiology, Radiology +16

Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort

Pedro David Wendel‐Garcia, Thierry Fumeaux, Philippe Guerci et al. · EClinicalMedicine · 2020 · 229 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +9

Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention

Xavier Freixa, Neus Bellera, Jose T. Ortiz‐Pérez et al. · European Heart Journal · 2011 · 226 citations · Full text

Medicine, Cardiology, Clinical Cardiology +15